Login / Signup
Exploration of Lasmiditan 200 mg Versus 100 mg for the Treatment of Migraine: A Meta-analysis Based on Aggregate Data.
Ting Wang
Yimo Feng
Published in:
Clinical neuropharmacology (2024)
Lasmiditan 200 mg is more effective to improve pain free at 2 hours and 24 hours than lasmiditan 100 mg for the acute treatment of migraine patients.
Keyphrases
</>
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
chronic pain
liver failure
pain management
machine learning
peritoneal dialysis
spinal cord injury
combination therapy
big data
deep learning
extracorporeal membrane oxygenation
smoking cessation